Toggle Main Menu Toggle Search


The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice

Lookup NU author(s): Huw Thomas, Suzanne Kyle, Ivanda Pavlovska, Professor Nicola Curtin


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Ali M, Kamjoo M, Thomas HD, Kyle S, Pavlovska I, Babur M, Telfer BA, Curtin NJ, Williams KJ

Publication type: Article

Journal: Molecular Cancer Therapeutics

Year: 2011

Volume: 10

Issue: 12

Pages: 2320-2329

Print publication date: 01/12/2011

ISSN (print): 1535-7163

ISSN (electronic): 1538-8514

Publisher: American Association for Cancer Research


DOI: 10.1158/1535-7163.MCT-11-0356


Altmetrics provided by Altmetric


    Link to this publication